Medicare Enrolled

Dr. Kathy Robb, NP

Nurse Practitioner - Family · Bakersfield, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
3801 SAN DIMAS ST, Bakersfield, CA 93301
6613238477
In practice since 2008 (18 years)
NPI: 1639347248 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Robb from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Robb? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Robb

Dr. Kathy Robb is a nurse practitioner - family in Bakersfield, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Robb performed 1,508 Medicare services across 757 unique beneficiaries.

Between the years covered by Open Payments, Dr. Robb received a total of $15,548 from 68 pharmaceutical and/or device companies across 687 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nurse practitioner - family. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Robb is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ Top 9% volume in CA $15,548 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,508
Medicare services
Top 9% in CA for nurse practitioner - family
757
Unique beneficiaries
$85
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~84 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
1,170 $81 $408
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
201 $125 $569
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
137 $57 $288
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$15,548
Total received (2021-2024)
Avg $3,887/year across 4 years
Top 1% in CA for nurse practitioner - family
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
68
Companies
687
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,014 (96.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$534 (3.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$5,165
2023
$4,326
2022
$3,618
2021
$2,439

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Daiichi Sankyo Inc.
$714
Janssen Biotech, Inc.
$519
GlaxoSmithKline, LLC.
$511
Lilly USA, LLC
$355
SOBI, INC
$263
Astellas Pharma US Inc
$241
PFIZER INC.
$236
Exelixis Inc.
$197
Eisai Inc.
$153
Celgene Corporation
$153
Blueprint Medicines Corporation
$150
Novartis Pharmaceuticals Corporation
$148
SUN PHARMACEUTICAL INDUSTRIES INC.
$127
ViiV Healthcare Company
$125
Genentech USA, Inc.
$116
Stemline Therapeutics Inc.
$105
Takeda Pharmaceuticals U.S.A., Inc.
$104
Regeneron Healthcare Solutions, Inc.
$100
PUMA BIOTECHNOLOGY, INC.
$98
Alexion Pharmaceuticals, Inc.
$92
AstraZeneca Pharmaceuticals LP
$82
PharmaEssentia USA Corporation
$78
Genmab U.S., Inc.
$75
ABBVIE INC.
$74
Agios Pharmaceuticals, Inc.
$55
ADC Therapeutics America, Inc.
$41
EMD Serono, Inc.
$40
Karyopharm Therapeutics Inc.
$35
E.R. Squibb & Sons, L.L.C.
$31
GENZYME CORPORATION
$29
ARRAY BIOPHARMA INC
$28
RECORDATI_RARE_DISEASES_INC.
$24
Deciphera Pharmaceuticals Inc.
$20
JAZZ PHARMACEUTICALS INC.
$19
Incyte Corporation
$17
Rigel Pharmaceuticals, Inc.
$11
Top 3 companies account for 33.8% of 2024 payments
All-time payments by company (2021-2024) ›
Daiichi Sankyo Inc.
$1,246
Janssen Biotech, Inc.
$1,194
GlaxoSmithKline, LLC.
$1,073
Seagen Inc.
$898
Amgen Inc.
$740
Celgene Corporation
$670
Takeda Pharmaceuticals U.S.A., Inc.
$660
PFIZER INC.
$548
Astellas Pharma US Inc
$515
Exelixis Inc.
$486
SOBI, INC
$453
E.R. Squibb & Sons, L.L.C.
$412
AstraZeneca Pharmaceuticals LP
$404
Pharmacyclics LLC, An AbbVie Company
$361
Lilly USA, LLC
$355
GENZYME CORPORATION
$348
Novartis Pharmaceuticals Corporation
$311
Regeneron Healthcare Solutions, Inc.
$309
Blueprint Medicines Corporation
$304
Genentech USA, Inc.
$290
Stemline Therapeutics Inc.
$284
Eisai Inc.
$266
Karyopharm Therapeutics Inc.
$237
Pharmacyclics LLC, an AbbVie Company
$233
Incyte Corporation
$220
AMAG Pharmaceuticals, Inc.
$164
SUN PHARMACEUTICAL INDUSTRIES INC.
$164
PUMA BIOTECHNOLOGY, INC.
$129
Puma Biotechnology, Inc.
$128
ViiV Healthcare Company
$125
Secura Bio, Inc.
$123
AVEO Pharmaceuticals, Inc.
$119
Bayer HealthCare Pharmaceuticals Inc.
$116
Alexion Pharmaceuticals, Inc.
$111
EMD Serono, Inc.
$109
Aadi Bioscience, Inc.
$87
Merck Sharp & Dohme LLC
$86
Rigel Pharmaceuticals, Inc.
$84
Dendreon Pharmaceuticals LLC
$82
PharmaEssentia USA Corporation
$78
Genmab U.S., Inc.
$75
Gilead Sciences, Inc.
$74
ABBVIE INC.
$74
Blue Earth Diagnostics Limited
$67
Apellis Pharmaceuticals, Inc.
$61
JAZZ PHARMACEUTICALS INC.
$56
Agios Pharmaceuticals, Inc.
$55
Sun Pharmaceutical Industries Inc.
$47
RECORDATI_RARE_DISEASES_INC.
$46
ADC Therapeutics America, Inc.
$41
Deciphera Pharmaceuticals Inc.
$39
Dova Pharmaceuticals
$38
Bayer Healthcare Pharmaceuticals Inc.
$37
BeiGene USA, Inc.
$33
Cumberland Pharmaceuticals, Inc.
$30
ARRAY BIOPHARMA INC
$28
Boehringer Ingelheim Pharmaceuticals, Inc.
$28
ImmunoGen, Inc.
$23
Pharmacosmos Therapeutics Inc.
$21
Myriad Genetic Laboratories, Inc.
$19
Kyowa Kirin, Inc.
$18
Epizyme, Inc.,
$18
MorphoSys, US Inc.
$18
Biogen, Inc.
$18
Myovant Sciences Inc.
$17
Acerta Pharma LLC
$16
Coherus Biosciences Inc.
$16
Ipsen Biopharmaceuticals, Inc
$16
Top 3 companies account for 22.6% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ADUHELM · ALUNBRIG · AYVAKIT · Axumin · BAVENCIO · BESREMI · BLENREP · BRAFTOVI · BRUKINSA · Blincyto · CABENUVA · CABLIVI · CABOMETYX · CALQUENCE · CARVYKTI · Cabometyx · Columvi · DARZALEX · DOPTELET · Doptelet · ELITEK · ELREXFIO · ELZONRIS · ENHERTU · ENJAYMO · EPKINLY · ERLEADA · EXKIVITY · Elahere · Empaveli · Enhertu · Epkinly · Erivedge · FARYDAK · FERAHEME · FOTIVDA · FRUZAQLA · Fyarro · GAZYVA · GILOTRIF · Gazyva · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INREBIC · Itovebi · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · Kyprolis · LIBTAYO · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · MONJUVI · MONOFERRIC · NERLYNX · NINLARO · Nplate · Nubeqa · OJJAARA · OPDIVO · OPDUALAG · ORGOVYX · Orserdu · PADCEV · PEMAZYRE · PLUVICTO · POTELIGEO · PROLARIS · PROMACTA · PROVENGE · PYRUKYND · Padcev · Phesgo · Pomalyst · QINLOCK · REBLOZYL · RYBREVANT · Rezlidhia · Rituxan · SANCUSO · SARCLISA · SHINGRIX · SYLVANT · Stivarga · TAGRISSO · TAZVERIK · TECVAYLI · TEPMETKO · TIVDAK · TRELEGY ELLIPTA · TUKYSA · Tazverik · Tecentriq · ULTOMIRIS · Udenyca · Ultomiris · VENCLEXTA · VERZENIO · VONJO · Vanflyta · Vyloy · XALKORI · XGEVA · XPOVIO · XYNTHA · Xospata · Xtandi · YONSA · ZEJULA · ZEPZELCA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 1% for nurse practitioner - family in CA.

Looking for a nurse practitioner - family in Bakersfield?
Compare family nurse practitioners in the Bakersfield area by procedure volume, costs, and industry payment transparency.
Browse family nurse practitioners nearby

Geographic Context

Family nurse practitioners within 10 mi
360
Per 100K population
39.5
County median income
$67,660
Nearest hospital
BAKERSFIELD MEMORIAL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Robb is a clinical cardiology specialist, with above-average Medicare volume (top 9% in CA), with low-engagement industry engagement in the top 1% of CA peers, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Robb experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Robb performed 1,170 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Robb receive payments from pharmaceutical companies?
Yes. Dr. Robb received a total of $15,548 from 68 companies across 687 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Robb's costs compare to other family nurse practitioners in Bakersfield?
Dr. Robb's average Medicare payment per service is $85. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Robb) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →